• About
  • Subscribe
  • Advertise
  • Contact
Friday, March 13, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Beyond the diagnosis: Why holistic eye health matters more than ever

by Myles Hume
July 8, 2025
in Feature, Local, News, Ophthalmic insights, Ophthalmic organisations, Patient support bodies, Report
Reading Time: 3 mins read
A A
A holistic approach extends care beyond the clinical setting, and considers mental wellbeing, access to assistive technology, communication needs, and quality-of-life, SeeWay says. Image: Ievgen Skrypko/stock.adobe.com.

A holistic approach extends care beyond the clinical setting, and considers mental wellbeing, access to assistive technology, communication needs, and quality-of-life, SeeWay says. Image: Ievgen Skrypko/stock.adobe.com.

Share on FacebookShare on Twitter

When people dealing with vision loss are supported to learn how to adapt, and feel emotionally supported, their outcomes improve in many ways, writes SeeWay communications lead HOLLY KELLY.

As eyecare professionals, we know that vision loss doesn’t happen in isolation. A clinical diagnosis is often just the beginning, and for the person on the receiving end, it marks a profound shift in how they see, move through, and experience the world.

Holly Kelly. Image: SeeWay.

Yet in the current system, patients with permanent low vision who are not legally blind are often left to navigate that shift without access to government supports or services. This is where holistic care becomes essential.

Recent research and digital landscape analysis have revealed a stark reality: Australians with low vision are actively searching for answers – more than 130,000 vision-related queries are made on Google every month – yet the results served up are most often fragmented, fear-inducing, and largely from international sources. Up to 86% of online information in this space originates overseas and lacks local relevance or support pathways.

At the same time, four in five people with low vision are never referred to support services at all. These missed opportunities can lead to avoidable emotional distress, social withdrawal, digital exclusion, and loss of confidence – especially for those who are still adjusting to their diagnosis.

A holistic approach to eye health extends care beyond the clinical setting. It considers mental wellbeing, access to assistive technology, communication needs, and quality-of-life. Studies show that people with vision loss are twice as likely to experience depression and anxiety, and that family carers are also at heightened risk of emotional strain.

The good news is that early, personalised support can make a significant difference. When people are supported to learn how to adapt, and feel emotionally supported, their outcomes improve – socially and psychologically.

That’s why SeeWay was created: a national, free support platform for people with low vision who are not eligible for funded care. SeeWay offers access to no-gap professional counselling, personalised digital literacy training and accessible practical resources to complement clinical care.

For eyecare professionals, referring to SeeWay is a simple, meaningful way to extend care for your patients. It helps patients feel seen, heard, and equipped – right from the moment their vision begins to change.

Referrals are now open, visit: SeeWay.com.au

More reading

SeeWay launches national support platform for people with low vision

Guide Dogs Victoria and its “more than dogs” approach

Guide Dogs NSW research reveals disability stigma

Related Posts

Bausch + Lomb’s new enVista Aspire intermediate-optimised IOL. Image: B+L.

Intermediate-optimised IOL bringing patient success

by Rob Mitchell
March 13, 2026

An ophthalmologist in New Zealand was the first in the Southern Hemisphere to try Bausch + Lomb’s new enVista Aspire...

Dr Michele Ginocchietti. Image: EssilorLuxottica

Global executive appointed to lead EssilorLuxottica in ANZ

by Staff Writer
March 12, 2026

Dr Michele Ginocchietti has been appointed head of ANZ at EssilorLuxottica, bringing more than a decade of experience within the...

55.2% of children wearing Abiliti 1-Day showed no clinically meaningful myopia progression* over three years.^1. Image: J &J Vision.

Putting compliance first – new data for ACUVUE Abiliti 1‑Day reinforces efficacy, wearability

by Staff Writer
March 12, 2026

Johnson & Johnson Vision (J&J Vision) says the myopia conversation in optometry practice has shifted from “if” to “when” and...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited